HERG1 channels regulate VEGF-A secretion in human gastric cancer: Clinicopathological correlations and therapeutical implications

Clinical Cancer Research

Volumn 20, Issue 6, 2014, Pages 1502-1512

  Crociani, Olivia ^a   Lastraioli, Elena ^a   Boni, Luca ^c   Pillozzi, Serena ^a   Romoli, Maria Raffaella ^a   D'Amico, Massimo ^a   Stefanini, Matteo ^a   Crescioli, Silvia ^a   Taddei, Antonio ^b   Bencini, Lapo ^d   Bernini, Marco ^d   Farsi, Marco ^d   Beghelli, Stefania ^f   Scarpa, Aldo ^f   Messerini, Luca ^a   Tomezzoli, Anna ^h   Vindigni, Carla ⁱ   Morgagni, Paolo ^k   Saragoni, Luca ^k   Giommoni, Elisa ^e   Gasperoni, Silvia ^e   Di Costanzo, Francesco ^e   Roviello, Franco ^j   De Manzoni, Giovanni ^g   Bechi, Paolo ^b   Arcangeli, Annarosa ^a   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Clinical Trials Coordinating Center   (Italy)

^d Azienda Ospedaliero Universitaria   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f Department of Pathology and Diagnostics ^*  (Italy)

^g UNIVERSITY OF VERONA   (Italy)

^h BORGO TRENTO HOSPITAL   (Italy)

ⁱ UNIVERSITY HOSPITAL OF SIENA   (Italy)

^j UNIVERSITY OF SIENA   (Italy)

^k MORGAGNI PIERANTONI HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; BEVACIZUMAB; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL HERG1; UNCLASSIFIED DRUG; VASCULOTROPIN A; ERG1 POTASSIUM CHANNEL; VEGFA PROTEIN, HUMAN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; METABOLISM; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION (PROCESS); STOMACH TUMOR; TUMOR CELL LINE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHER-A-GO-GO POTASSIUM CHANNELS; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896523793     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-2633     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst 2008;100:388-98.
3. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 2009;16:66-93.
4. Prevarskaya N, Skryma R, Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 2010;16:107-21.
5. Pedersen SF, Stock C. Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. Cancer Res 2013; 73:1658-61.
6. Munaron L, Arcangeli A. Editorial: ion fluxes and cancer. Recent Pat Anticancer Drug Discov 2013;8:1-3.
7. Arcangeli A. Expression and role of hERG channels in cancer cells. Novartis Found Symp 2005;266:225-32; discussion 232-4.
8. Jehle J, Schweizer PA, Katus HA, Thomas D. Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis 2011;2: e193.
9. Fontana L, D'Amico M, Crociani O, Biagiotti T, Solazzo M, Rosati B, et al. Long-term modulation of HERG channel gating in hypoxia. Biochem Biophys Res Commun 2001;286:857-62.
10. Masi A, Becchetti A, Restano-Cassulini R, Polvani S, Hofmann G, Buccoliero AM, et al. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br J Cancer 2005;93:781-92.
11. Pillozzi S, Brizzi MF, Bernabei PA, Bartolozzi B, Caporale R, Basile V, et al. VEGFR-1 (FLT-1), b1 integrin and hERG K+ channel form a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 2007;110:1238-50.
12. Lastraioli E, Gasperi Campani F, Taddei A, Giani I, Messerini L, Comin CE, et al. hERG1 channels are overexpressed in human gastric cancer and their activity regulates cell proliferation: a novel prognostic and therapeutic target? Proceedings of 6th IGCC; 2005; Yokohama, Japan. p 151-4.
13. Shao X-D, Wu KC, Hao ZM, Hong L, Zhang J, Fan DM. The potent inhibitory effects of cisapride, a specific blocker for human ether-A-gogo related gene (HERG) channel, on gastric cells. Cancer Biol Ther 2005;4:295-301.
14. Shao XD, Wu KC, Guo XZ, Xie MJ, Zhang J, Fan DM. Expression and significance of HERG protein in gastric cancer. Cancer Biol Ther 2008;7:45-50.
15. Ding X-W, Yang WB, Gao S, Wang W, Li Z, Hu WM, et al. Prognostic significance of hERG1 expression in gastric cancer. Dig Dis Sci 2010; 55:1004-10.
16. Lastraioli E, Guasti L, Crociani O, Polvani S, Hofmann G, Witchel H, et al. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 2004; 64:606-11.
17. Lastraioli E, Bencini L, Bianchini E, Romoli MR, Crociani O, Giommoni E, et al. hERG1 channels and Glut-1 as independent prognostic indicators of worse outcome in stage I and II colorectal cancer: a pilot study. Transl Oncol 2012;5:105-12.
18. Luo X, Xiao J, Lin H, Lu Y, Yang B, Wang Z. Genomic structure, transcriptional control, and tissue distribution of HERG1 and KCNQ1 genes. Am J Physiol Heart CircPhysiol 2008;294:H1371-80.
19. Crociani O, Guasti L, Balzi M, Becchetti A, Wanke E, Olivotto M, et al. Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem 2003;278:2947-55.
20. Guasti L, Crociani O, Redaelli E, Pillozzi S, Polvani S, Masselli M, et al. Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. Mol Cell Biol 2008;28:5043-60.
21. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33:207-14.
22. Crociani O, Zanieri F, Pillozzi S, Lastraioli E, Stefanini M, Fiore A, et al. hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer. Sci Rep 2013;3:3308.
23. Marrelli D, Pedrazzani C, Corso G, Neri A, Di Martino M, Pinto E, et al. Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. Ann Surg 2009; 250:43-50.
24. Heitzmann D, Warth R. No potassium, no acid: K+ channels and gastric acid secretion. Physiology (Bethesda) 2007;22:335-41.
25. Kopic S, Geibel JP. Update on the mechanisms of gastric acid secretion. Curr Gastroenterol Rep 2010;12:458-64.
26. Um SY, McDonald TV. Differential association between HERG and KCNE1 or KCNE2. PLoS ONE 2007;2:e933.
27. Fiore A, Carraresi L, Morabito A, Polvani S, Fortunato A, Lastraioli E, et al. Characterization of hERG1 channel role in mouse colorectal carcinogenesis. Cancer Med 2013;2:583-94.
28. Schönherr R, Rosati B, Hehl S, Rao VG, Arcangeli A, Olivotto M, et al. Functional role of the slow activation property ofERGK+channels. Eur J Neurosci 1999;11:753-60.
29. Arcangeli A, Pillozzi S, Becchetti A. Targeting ion channels in leukemias: a new challenge for treatment. Curr Med Chem 2012;19: 683-96.
30. Liu L, Ma XL, Xiao ZL, Li M, Cheng SH, Wei YQ. Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev 2012;13:3089-97.
31. Yamashita-Kashima Y, Fujimoto-Ouchi K, Yorozu K, Kurasawa M, Yanagisawa M, Yasuno H, et al. Biomarkers for antitumor activity of bevacizumab in gastric cancer models. BMC Cancer 2012;12:37.
32. Pillozzi S, Masselli M, De Lorenzo E, Accordi B, Cilia E, Crociani O, et al. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood 2011; 117:902-14.
33. Sennino B, Mc Donald DM. Controlling escape from angiogenesis inhibitors. Nat Rev Cancer 2012;12:699-709.